Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-27

Clinical Trial Update: Effect of Metabolaid® on AMPK Activation for Weight Loss [NA]

View source ↗

Summary

A completed clinical trial evaluating Metabolaid's effect on AMPK activation for weight loss in metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metabolaid

Snippet

Sponsor: Universidad Miguel Hernandez de Elche | Conditions: Metabolic Syndrome | NA | Status: COMPLETED